vincristine / Generic mfg.  >>  Phase 4
Welcome,         Profile    Billing    Logout  

17 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
vincristine / Generic mfg.
2005-005085-36: Ihobiopsia neurotoksista sytostaattiadjuvanttihoitoon liittyvän Neuropatian diagnostiikassa

Ongoing
4
60
Europe
Intravenous infusion, Taxotere, Oncovin,Eloxatin
Anna-Liisa Kautio
cancer
 
 
ChiCTR-TNC-09000394: LVP protocol in combination with radiotherapy for untreated NK/T lymphoma patients

Completed
4
30
 
LVP(L-asparaginase 6000IU/m2 d1-5+Vincristine 1.4mg/m2 d1,no more than 2mg + prednisoned 45mg d1-5+)repeated every 21 days;radiotherapy
Department of Medical Oncology, Cancer Center, West China Hospital of Sichuan University; Level of the institution：, Self-funding
NK/T lymphoma (I/II stage)
 
 
2013-000052-17: Study to investigate the early prediction of toxicity following chemotherapy and differences in drug handling in Ewing's sarcoma patients

Ongoing
4
120
Europe
Cyclophosphamide, Etoposide, Doxorubicin, Vincristine, Ifosfamide, Powder for solution for injection, Concentrate for solution for infusion, Solution for infusion, Solution for injection, Powder for concentrate for solution for infusion, Cyclophosphamide, Eposin, Doxorubicin Hydrochloride, Vincristine Sulphate, Ifosfamide
The Newcastle Upon Tyne Hospitals NHS Foundation Trust
Ewing sarcoma patients, Bone cancer, Diseases [C] - Cancer [C04]
 
 
2014-001561-27: Neuropathy caused by vincristine in children with leukemia: comparing one-hour infusions with short-term infusions Neuropathie door vincristine bij kinderen met leukemie: één-uurs infusen vergeleken met kortdurende infusies

Ongoing
4
88
Europe
Vincristine sulfate, Vincristine Sulphate, VCR, Solution for infusion, Solution for injection
VU university medical center, The Netherlands Organisation for Health Research and Development (in Dutch: ZonMw)
Pediatric oncology, acute lymphoblastic leukemia, nephroblastoma, medulloblastoma, low-grade glioma, Hodgkin lymphoma, rhabdomyosarcoma Kinderoncologie, acute lymfatische leukemie, nefroblastoom, medulloblastoom, laaggradig glioom, Hodgkin lymfoom en rhabdomyosarcoom, Childhood cancer Kinderkanker, Diseases [C] - Cancer [C04]
 
 
2004-001199-37: A Phase II, Single Arm, Open label Study of Cyclophosphamide, Vincristine, Liposomal Doxorubicine (Myocet™) and Prednisone plus Rituximab in Fortnightly Regimen (R-COMP-14), as First Line of therapy for Patients with Aggressive Non Hodgkin’s Lymphoma (NHL).

Ongoing
4
75
Europe
cyclophosphamide, Vincristine, Prednisone, Rituximab, Myocet, Myocet
(GOTEL) Grupo Oncológico para el tratamiento y estudio de los linfomas
Dose-dense modified R-CHOP regimen (R-COMP) in patients with aggressive NHL.
 
 
2005-002345-39: B-NHL BFM 04

Ongoing
4
20
Europe
Dexacortal, Methotrexate, Sendoxan, Adriamycin, Oncovin STADAPharm, Cytarabine Pharmacia, Vepesid, Holoxan, Precortalon Aquosum, Eldisine, Myleran, Thiotepa, Neupogen, Methotrexate Pharmacia, 14320, Dexametasone, Metotrexat, Cyclophosfamide, Adriamycin, Vincristine, Cytarabine, Etoposide, Ifosfamide, Prednisolone, Vindesin, Busulfan, Thiotepa, Filgrastin, Methotrexate, Dexametasone, Metotrexat, Cyclophosfamide, Adriamycin, Vincristine, Cytarabine, Etoposide, Ifosfamide, Prednisolone, Vindesin, Busulfan, Thiotepa, Filgrastin, Methotrexate
NOPHO NHL-group
B-cell lymphoma or B-ALL in children up to 18 years of age
 
 
ChiCTR1800020142: The clinical study on the efficacy and safety of CDOP regimen with pegylated liposomal doxorubicin ± rituximab in the treatment of diffuse large B-cell lymphoma

Recruiting
4
300
 
PLD 25 mg/ m2，iv，d1，cyclophosphamide 750 mg/m2, vincristine 1.4 mg/m2, up to 2 mg, or vindesine 3 mg/m2, intravenously (iv.) all on day 1; and prednisone 100 mg orally on days 1 to 5, with or without rituximab 375 mg/m2, iv. on day 0, administered every 21 days (n=304) for six or eight cycle
Beijing Cancer Hospital; Beijing Cancer Hospital, CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.
diffuse large B-cell lymphoma
 
 
GAZELLE, NCT03817853: An Open-Label, Single Arm Study of Obinutuzumab Short Duration Infusion in Patients With Previously Untreated Advanced Follicular Lymphoma

Completed
4
114
Europe, Japan, US, RoW
Obinutuzumab, GA101, RO5072759, Bendamustine, Cyclophosphamide, Doxorubicin, Prednisone/Prednisolone/Methylprednisolone, Vincristine
Hoffmann-La Roche
Advanced Follicular Lymphoma
08/20
01/23
NCT03892330: Combination Therapy of Anthracyclines for Children With Nephroblastoma

Not yet recruiting
4
120
RoW
Vincristine, Oxytetracycline/ Cyclophosphamide, Liposomal doxorubicin, Doxorubicin, Pharmorubicin, Pirarubicin
Shengjing Hospital
0.5-14 Year Old Children With Nephroblastoma
12/20
06/45
NCT02752815: Reduced Chemotherapy in Low Risk DLBCL

Active, not recruiting
4
290
RoW
Rituximab, Cyclophosphamide, Epirubicin, Vincristine, Prednisone
Ruijin Hospital
Diffuse Large B-cell Lymphoma
10/22
12/24
PETHEMA LAL-07FRAIL , NCT01358201: PETHEMA LAL-07FRAIL: All Treatment In Fragile Patients Ph' Negative Over 55 Years

Recruiting
4
100
Europe
vINCRISTINE, Dexamethasone, Methotrexate, Cytosine arabinoside
PETHEMA Foundation
Acute Lymphoblastic Leukemia
12/22
12/22
NCT04842318: Rituximab Maintenance Treatment of Newly Diagnosed Follicular Lymphoma After BR or RCHOP or R2: a Multicenter Clinical Study

Recruiting
4
789
RoW
BR for 6 cycles +R for 8 cycles, RCHOP for 6 cycles +R for 8 cycles, R2 for 6 cycles + R2 maintenance
Ruijin Hospital
Follicular Lymphoma
03/23
03/24
NCT06289673: Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

Not yet recruiting
4
850
US
Dexamethasone, Decadron, Vincristine, Vincristine Sulfate, Oncovin, Daunorubicin, Daunomycin, Intrathecal triple therapy (methotrexate + hydrocortisone + cytarabine), ITMHA, Methotrexate, MTX, Trexall®, Cytarabine, Cytosine arabinoside, Ara-C
St. Jude Children's Research Hospital
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Mixed Phenotype Acute Leukemia
05/34
05/39
CHAPATI, NCT05844670: CHildren Treated With Vincristine: A Trial Regarding Pharmacokinetics, DNA And Toxicity of Targeted Therapy In Pediatric Oncology Patients.

Recruiting
4
100
RoW
Vincristine
Moi University, Princess Maxima Center for Pediatric Oncology, Amsterdam UMC, location VUmc
Pediatric Cancer
08/24
11/24
NCT02875314: HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors

Active, not recruiting
4
250
Canada, US, RoW
Induction, vincristine, cisplatin, cyclophosphamide, etoposide, high-dose methotrexate, Single Cycle Intensive Chemotherapy, Carboplatin, thiotepa, etoposide, Tandem 3 Cycle Intensive Chemotherapy, Carboplatin, thiotepa
Parth Patel, Children's of Alabama
Medulloblastoma, Central Nervous System Embryonal Tumors
12/24
12/30
NCT05518383: B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021

Recruiting
4
300
RoW
Cyclophosphamide, Cytarabine, Dexamethasone, Etoposide, Ifosfamide, Methotrexate, Cyclophosphamide, Cytarabine, Dexamethasone, Etoposide, Ifosfamide, Methotrexate, Vincristine, Cyclophosphamide, Cytarabine, Dexamethasone, Doxorubicin hydrochloride, Etoposide, Ifosfamide, Methotrexate, vincristine, Cyclophosphamide , Cytarabine, Dexamethasone, Doxorubicin hydrochloride, Etoposide, Ifosfamide, Methotrexate, Vincristine, Сarboplatine, CCNU/ BCNU, Melphalan, Idarubicin
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Non-hodgkin Lymphoma,B Cell, Burkitt Lymphoma, Primary Mediastinal Lymphoma, Primary CNS Lymphoma, Diffuse Large B-cell Lymphoma
05/25
05/27
ChiCTR2300075225: Safety and efficacy of Chidamide combined with chemotherapy in the treatment of newly diagnosed T-cell acute lymphoblastic leukemia in children: a multicenter randomized controlled study.

Not yet recruiting
4
160
 
Dexamethasone, vincristine, daunorubicin, asparaginase ;Dexamethasone, Vincristine, Daunorubicin, Asparaginase, Cedaramine
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, No
Childhood T-cell acute lymphoblastic leukemia
 
 

Download Options